4-amino-1-((2R,4R,5R)-5-((6,7-dihydropyrazolo[1,5-a]pyrazin-5(4H)-yl)methyl)-3,3-difluoro-4-hydroxytetrahydrofuran-2-yl)pyrimidin-2(1H)-one

ID: ALA3235144

Chembl Id: CHEMBL3235144

PubChem CID: 70350648

Max Phase: Preclinical

Molecular Formula: C15H18F2N6O3

Molecular Weight: 368.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccn([C@@H]2O[C@H](CN3CCn4nccc4C3)[C@@H](O)C2(F)F)c(=O)n1

Standard InChI:  InChI=1S/C15H18F2N6O3/c16-15(17)12(24)10(8-21-5-6-23-9(7-21)1-3-19-23)26-13(15)22-4-2-11(18)20-14(22)25/h1-4,10,12-13,24H,5-8H2,(H2,18,20,25)/t10-,12-,13-/m1/s1

Standard InChI Key:  MKUIYMQGVZUIHW-RAIGVLPGSA-N

Associated Targets(Human)

RRM1 Tclin Ribonucleoside-diphosphate reductase M1 chain (163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RRM1 Tclin Ribonucleotide reductase (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 368.34Molecular Weight (Monoisotopic): 368.1408AlogP: -0.57#Rotatable Bonds: 3
Polar Surface Area: 111.43Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.55CX Basic pKa: 5.29CX LogP: -0.86CX LogD: -0.86
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.75Np Likeness Score: -0.07

References

1. Labroli MA, Dwyer MP, Shen R, Popovici-Muller J, Pu Q, Wyss D, McCoy M, Barrett D, Davis N, Seghezzi W, Shanahan F, Taricani L, Beaumont M, Malinao MC, Parry D, Guzi TJ..  (2014)  The identification of novel 5'-amino gemcitabine analogs as potent RRM1 inhibitors.,  22  (7): [PMID:24588962] [10.1016/j.bmc.2014.02.007]

Source